全文获取类型
收费全文 | 15827篇 |
免费 | 1447篇 |
国内免费 | 7篇 |
出版年
2022年 | 100篇 |
2021年 | 231篇 |
2020年 | 141篇 |
2019年 | 210篇 |
2018年 | 204篇 |
2017年 | 199篇 |
2016年 | 364篇 |
2015年 | 577篇 |
2014年 | 653篇 |
2013年 | 882篇 |
2012年 | 1034篇 |
2011年 | 1055篇 |
2010年 | 629篇 |
2009年 | 621篇 |
2008年 | 855篇 |
2007年 | 882篇 |
2006年 | 772篇 |
2005年 | 818篇 |
2004年 | 777篇 |
2003年 | 713篇 |
2002年 | 704篇 |
2001年 | 192篇 |
2000年 | 167篇 |
1999年 | 187篇 |
1998年 | 206篇 |
1997年 | 147篇 |
1996年 | 129篇 |
1995年 | 115篇 |
1994年 | 120篇 |
1993年 | 105篇 |
1992年 | 118篇 |
1991年 | 110篇 |
1990年 | 101篇 |
1989年 | 98篇 |
1988年 | 89篇 |
1987年 | 98篇 |
1986年 | 106篇 |
1985年 | 94篇 |
1984年 | 133篇 |
1983年 | 109篇 |
1982年 | 133篇 |
1981年 | 135篇 |
1980年 | 148篇 |
1979年 | 116篇 |
1978年 | 111篇 |
1977年 | 122篇 |
1976年 | 87篇 |
1975年 | 91篇 |
1974年 | 98篇 |
1973年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Based on its proven anabolic effects on bone in osteoporosis patients, recombinant parathyroid hormone (PTH1-34) has been evaluated as a potential therapy for skeletal repair. In animals, the effect of PTH1-34 has been investigated in various skeletal repair models such as fractures, allografting, spinal arthrodesis and distraction
osteogenesis. These studies have demonstrated that intermittent PTH1-34 treatment enhances and accelerates the skeletal repair process via a number of mechanisms, which include effects on mesenchymal
stem cells, angiogenesis, chondrogenesis, bone formation and resorption. Furthermore, PTH1-34 has been shown to enhance bone repair in challenged animal models of aging, inflammatory arthritis and glucocorticoid-induced
bone loss. This pre-clinical success has led to off-label clinical use and a number of case reports documenting PTH1-34 treatment of delayed-unions and non-unions have been published. Although a recently completed phase 2 clinical trial of PTH1-34 treatment of patients with radius fracture has failed to achieve its primary outcome, largely because of effective healing
in the placebo group, several secondary outcomes are statistically significant, highlighting important issues concerning the
appropriate patient population for PTH1-34 therapy in skeletal repair. Here, we review our current knowledge of the effects of PTH1-34 therapy for bone healing, enumerate several critical unresolved issues (e.g., appropriate dosing regimen and indications)
and discuss the long-term potential of this drug as an adjuvant for endogenous tissue engineering. 相似文献
2.
3.
R M Arahuetes J López M Ramos 《Comparative biochemistry and physiology. B, Comparative biochemistry》1986,83(1):231-233
Glucose and ketone bodies production has been studied in hepatocytes isolated from fetuses at term of fed and fasted adrenalectomized mothers. Maternal adrenalectomy diminishes the fetal liver weight. This effect is increased when the adrenalectomized pregnant rat is fasted for the last 2 days of gestation. Maternal adrenalectomy diminishes glucose production in hepatocytes isolated from fetuses at term. This diminution is markedly greater when the adrenalectomized pregnant rat is fasted for the last 48 hr of gestation. Maternal adrenalectomy diminishes ketone bodies production in hepatocytes isolated from fetuses at term. 相似文献
4.
5.
Edward Harrison 《BMJ (Clinical research ed.)》1916,1(2888):645-647
6.
Transcriptional regulatory network triggered by oxidative signals configures the early response mechanisms of japonica rice to chilling stress 总被引:3,自引:0,他引:3
7.
Injection of manganese into the rat corpus striatum causes a rapid fall in the biopterin and dopamine (DA) content ipsilateral to the lesion. Two weeks after the lesion both biopterin and DA are partially recovered. Controls, injected with saline or magnesium, do not show alterations in their DA or cofactor levels. It is proposed that the fall in DA levels results from a rapid displacement of the amine from its storage sites by manganese followed by a decrease in the rate of DA synthesis causes by the drop in cofactor levels. 相似文献
8.
9.
10.